logo
Site Network

Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. MD Anderson Cancer Center Madrid

+34912777220
info@mdanderson.es
Source: Site record.
https://www.mdandersonhospiten.es

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

MD Anderson Madrid is currently a leading referral center of excellence for cancer treatment in Spain and Europe, thanks to its team of highly specialized professionals, outstanding facilities, and continuous close collaboration with MD Anderson Cancer Center in Houston.In addition, MD Anderson Madrid has internationally renowned research teams among its professionals, enabling it to offer patients the latest advances in cancer diagnosis and treatment.

Business Status

Source: Human-provided. OPEN

Business Category

Source: Human-provided. Hospital

Business Subcategory

Source: Human-provided. Hospital
Source: Human-provided. Cancer treatment center
Source: Human-provided. Medical Center
Source: Trial-derived.
41Total Trials
Source: Trial-derived.
5Recruiting Trials
Source: Trial-derived.
9Active Trials
Source: Trial-derived.
0Completed Trials
Source: Trial-derived.
53Unique Conditions
Source: Trial-derived.
42Unique Sponsors

Conditions

Source: Trial-derived. Breast Cancer (5)Source: Trial-derived. Acute Myeloid Leukemia (3)Source: Trial-derived. Ovarian Cancer (3)Source: Trial-derived. Lymphoma (2)Source: Trial-derived. Adult Disease (1)Source: Trial-derived. Adult Solid Tumor (1)Source: Trial-derived. Advanced Adenomas (AA) (1)Source: Trial-derived. Advanced Breast Cancer (1)

Sponsors

Source: Trial-derived. Hoffmann-La Roche (5)Source: Trial-derived. Merck Sharp & Dohme LLC (3)Source: Trial-derived. ADVANCED MARKER DISCOVERY S.L. (2)Source: Trial-derived. Amgen (2)Source: Trial-derived. BioNTech SE (2)Source: Trial-derived. Bristol-Myers Squibb (2)Source: Trial-derived. Genentech, Inc. (2)Source: Trial-derived. Incyte Corporation (2)

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. CT Scan
Source: AI-inferred. SPECT / nuclear medicine

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Timed pharmacokinetic sampling and processing
Source: AI-inferred. Histology / pathology
Source: AI-inferred. Immunogenicity (anti-drug antibody) testing
Source: AI-inferred. Specimen packaging and shipment
Source: AI-inferred. Pharmacokinetic bioanalysis
Source: AI-inferred. PCR / molecular
Source: AI-inferred. Circulating tumour DNA testing

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Tumour tissue biopsy (guidance not stated)
Source: AI-inferred. Radiopharmaceutical handling and administration

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. FLT3 mutation testing
Source: AI-inferred. HER2 status testing
Source: AI-inferred. Ophthalmologic examination
Source: AI-inferred. Ophthalmologic examination (retinal assessment)
Source: AI-inferred. Tumor Treating Fields device therapy administration
Source: AI-inferred. Tumour EGFR mutation testing